The Department of the Air Force Materiel Command Research Laboratory awarded a $749,991 firm fixed price purchase order to Definitive Biotechnologies, LLC as part of the Small Business Innovation Research Program Phase II Action. Under this contract, Definitive Biotechnologies will deliver a disposable, multiplex molecular device for simultaneous point-of-care diagnosis of coronavirus disease 2019 and influenza. The contract has a total small business set aside designation. Performance will...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Firebird Biomolecular Sciences LLC, a for-profit limited liability company, for the project "REAL-TIME ASSESSMENT OF ANTIMICROBIAL CONCENTRATIONS FOR PERSONALIZED TREATMENT OF INFECTIOUS DISEASES." The $150,000.00 fixed-price contract was awarded on December 12, 2016 with a completion date of January 11, 2018. Firebird Biomolecular Sciences LLC is a...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Mbio Diagnostics Inc., doing business as Lightdeck Diagnostics, for the development of a "Point of Care Host-Pathogen Monitoring System." The fixed-price contract has a ceiling value of $149,503.39 and was awarded on November 18, 2016, with a completion date of November 27, 2017. Mbio Diagnostics Inc. is a for-profit organization that develops...
This is a Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Probiusdx Inc., a small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development of point-of-care technologies to monitor and characterize host-pathogen interactions during acute severe infection. The contract has a ceiling value of $147,130.17 and an ultimate completion date of November 24, 2017. The contract is set aside for small...
This is a firm fixed price purchase order contract awarded by the Defense Health Agency (DHA) to Biofire Defense LLC, a manufacturer of biological agent identification products. The contract is for the delivery of MOLECULAR DIAGNOSTICS KITS and has a ceiling value of $3,498,082.42 with a period of performance through September 29, 2029. There is no set-aside designation for this contract. Biofire Defense LLC has previously been awarded other prime and subcontract work with the Department of...
This is a firm fixed price purchase order contract awarded by the Defense Health Agency to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract is for $632,736.78 to provide a respiratory panel for the Walter Reed National Military Medical Center, with a period of performance through May 25, 2024. The contract has no set-aside designation. Biofire Defense has previously received other federal contracts and grants...
This is a $2,999,999.66 Firm Fixed Price contract awarded by the Defense Health Agency (DHA) to JAN Biotech, Inc. (JBI), a woman-owned small business. The contract is for JBI to provide research and development services under the Small Business Innovation Research (SBIR) program, specifically for sample collection and processing methods to support battlefield wound infection diagnostics. The contract has a total small business set aside designation and a performance period ending on January...
This is a $1,249,994.00 Small Business Innovation Research (SBIR) Phase II contract awarded by the U.S. Air Force Research Laboratory to Dxlab Inc., a for-profit organization based in Somerville, Massachusetts. The contract is for the development of a portable and rugged infection diagnostic platform that can provide rapid, clinically actionable pathogen detection at deployed locations and military treatment facilities. The contract has a performance period through July 13, 2026 and is...
This is a $2,474,747.75 fixed-price purchase order awarded by the Defense Health Agency to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, for the provision of testing kits and panels for Bloodstream Infections, COVID-19, Meningitis/Encephalitis, and other infectious diseases. The contract has an ultimate completion date of April 29, 2026 and does not utilize a set-aside designation. Biofire Diagnostics LLC is an experienced federal contractor, holding several indefinite...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a Firm Fixed Price purchase order contract to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products, for a FILM ARRAY TORCH SYSTEM. The $225,000.00 contract has a completion date of May 10, 2024. This award is not associated with a larger contract vehicle and does not have a socioeconomic set-aside designation. Biofire Defense has a...